Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction

Abroad (travel likely)RecruitingPHASE3

Conditions

Acute Myocardial Infarction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Seoul National University Hospital, Seoul, South Korea
Contact: Study coordinator (Jeehoon Kang, MD, PhD) · medikang@gmail.com · +82-2-2072-1181
Contact: Study coordinator (Hyun-Jai Cho, MD, PhD)

Study leads

Hyun Jai Cho, MD
Principal Investigator
Seoul National University Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome

MYOCARDIAL INFARCTION

Abroad (travel likely)RecruitingPHASE3

Paris, France

Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes

Myocardial Infarction · Acute Coronary Syndrome · Diabetes

Abroad (travel likely)RecruitingPHASE2, PHASE3

São Paulo, Brazil

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk · Acute Myocardial Infarction (AMI)

IsraelRecruitingPHASE3

Alexander City, United States · Birmingham, United States

Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction

Cardiogenic Shock · Myocardial Infarction

Abroad (travel likely)RecruitingPHASE4

Amsterdam, Netherlands